Recent Securities Litigations

Spectrum Pharmaceuticals Inc.Common Stock (NASDAQ: SPPI)

Company Name:Spectrum Pharmaceuticals Inc.Common Stock
Stock Symbol:NASDAQ: SPPI
Class Period Start:01/31/2013
Class Period End (inclusive):09/16/2016

According to the law firm press release, the lawsuit alleges throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the FDA previously questioned whether the data from the 611 and 612 Studies were clinically meaningful; (2) the FDA advised defendants in December 2012 not to submit the New Drug Application based on data from the 611 and 612 Studies; and (3) as a result, defendants' public statements about Spectrum's business, operations and prospects were materially false and misleading at all relevant times.

On November 15, 2016, this action was transferred to the United States District Court for the District of Nevada.